Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration

Jérémie F. Cohen, Daniël A. Korevaar, Douglas G. Altman et al. · BMJ Open · 2016 · 2.5K citations · Full text

Public Health, Internal Medicine, Clinical Epidemiology +6

Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

James L. Mohler, Emmanuel S. Antonarakis, Andrew J. Armstrong et al. · Journal of the National Comprehensive Cancer Network · 2019 · 1.6K citations · Full text

Medicine, Oncology, Urology +17

Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial

Piet Ost, Dries Reynders, Karel Decaestecker et al. · Journal of Clinical Oncology · 2017 · 1.3K citations

Medicine, Oncology, Urology +17

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

Christopher Parker, Nicholas D. James, Chris Brawley et al. · The Lancet · 2018 · 1.3K citations · Full text

Medicine, Oncology, Urology +13

Assessment of ⁶⁸Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer

Wolfgang P. Fendler, Jérémie Calais, Matthias Eiber et al. · JAMA Oncology · 2019 · 787 citations · Full text

Medicine, Nuclear Medicine, Oncology +17